Request for Covid-19 Impact Assessment of this Report
The United States Drug-Device Combination Products market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drug-Device Combination Products market, reaching US$ million by the year 2028. As for the Europe Drug-Device Combination Products landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Drug-Device Combination Products players cover GSK, Novo Nordisk, Eli Lilly, and AstraZeneca, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Device Combination Products market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Drug-Coated Device
Prefilled Drug Delivery Systems
Nebulizer and Inhaler
Transdermal Delivery System
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital andClinic
Retail Pharmacies
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GSK
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
Boston Scientific
Abbott
Boehringer Ingelheim
Medtronic
Mylan
3M
Hisamitsu
Smith & Nephew
Molnlycke
Teleflex
BD
Lepu Medical
MicroPort
Terumo
B. Braun
Antares Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug-Device Combination Products Market Size 2017-2028
2.1.2 Drug-Device Combination Products Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drug-Device Combination Products Segment by Type
2.2.1 Drug-Coated Device
2.2.2 Prefilled Drug Delivery Systems
2.2.3 Nebulizer and Inhaler
2.2.4 Transdermal Delivery System
2.2.5 Others
2.3 Drug-Device Combination Products Market Size by Type
2.3.1 Drug-Device Combination Products Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drug-Device Combination Products Market Size Market Share by Type (2017-2022)
2.4 Drug-Device Combination Products Segment by Application
2.4.1 Hospital andClinic
2.4.2 Retail Pharmacies
2.4.3 Other
2.5 Drug-Device Combination Products Market Size by Application
2.5.1 Drug-Device Combination Products Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drug-Device Combination Products Market Size Market Share by Application (2017-2022)
3 Drug-Device Combination Products Market Size by Player
3.1 Drug-Device Combination Products Market Size Market Share by Players
3.1.1 Global Drug-Device Combination Products Revenue by Players (2020-2022)
3.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2020-2022)
3.2 Global Drug-Device Combination Products Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug-Device Combination Products by Regions
4.1 Drug-Device Combination Products Market Size by Regions (2017-2022)
4.2 Americas Drug-Device Combination Products Market Size Growth (2017-2022)
4.3 APAC Drug-Device Combination Products Market Size Growth (2017-2022)
4.4 Europe Drug-Device Combination Products Market Size Growth (2017-2022)
4.5 Middle East & Africa Drug-Device Combination Products Market Size Growth (2017-2022)
5 Americas
5.1 Americas Drug-Device Combination Products Market Size by Country (2017-2022)
5.2 Americas Drug-Device Combination Products Market Size by Type (2017-2022)
5.3 Americas Drug-Device Combination Products Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Device Combination Products Market Size by Region (2017-2022)
6.2 APAC Drug-Device Combination Products Market Size by Type (2017-2022)
6.3 APAC Drug-Device Combination Products Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug-Device Combination Products by Country (2017-2022)
7.2 Europe Drug-Device Combination Products Market Size by Type (2017-2022)
7.3 Europe Drug-Device Combination Products Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug-Device Combination Products by Region (2017-2022)
8.2 Middle East & Africa Drug-Device Combination Products Market Size by Type (2017-2022)
8.3 Middle East & Africa Drug-Device Combination Products Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug-Device Combination Products Market Forecast
10.1 Global Drug-Device Combination Products Forecast by Regions (2023-2028)
10.1.1 Global Drug-Device Combination Products Forecast by Regions (2023-2028)
10.1.2 Americas Drug-Device Combination Products Forecast
10.1.3 APAC Drug-Device Combination Products Forecast
10.1.4 Europe Drug-Device Combination Products Forecast
10.1.5 Middle East & Africa Drug-Device Combination Products Forecast
10.2 Americas Drug-Device Combination Products Forecast by Country (2023-2028)
10.2.1 United States Drug-Device Combination Products Market Forecast
10.2.2 Canada Drug-Device Combination Products Market Forecast
10.2.3 Mexico Drug-Device Combination Products Market Forecast
10.2.4 Brazil Drug-Device Combination Products Market Forecast
10.3 APAC Drug-Device Combination Products Forecast by Region (2023-2028)
10.3.1 China Drug-Device Combination Products Market Forecast
10.3.2 Japan Drug-Device Combination Products Market Forecast
10.3.3 Korea Drug-Device Combination Products Market Forecast
10.3.4 Southeast Asia Drug-Device Combination Products Market Forecast
10.3.5 India Drug-Device Combination Products Market Forecast
10.3.6 Australia Drug-Device Combination Products Market Forecast
10.4 Europe Drug-Device Combination Products Forecast by Country (2023-2028)
10.4.1 Germany Drug-Device Combination Products Market Forecast
10.4.2 France Drug-Device Combination Products Market Forecast
10.4.3 UK Drug-Device Combination Products Market Forecast
10.4.4 Italy Drug-Device Combination Products Market Forecast
10.4.5 Russia Drug-Device Combination Products Market Forecast
10.5 Middle East & Africa Drug-Device Combination Products Forecast by Region (2023-2028)
10.5.1 Egypt Drug-Device Combination Products Market Forecast
10.5.2 South Africa Drug-Device Combination Products Market Forecast
10.5.3 Israel Drug-Device Combination Products Market Forecast
10.5.4 Turkey Drug-Device Combination Products Market Forecast
10.5.5 GCC Countries Drug-Device Combination Products Market Forecast
10.6 Global Drug-Device Combination Products Forecast by Type (2023-2028)
10.7 Global Drug-Device Combination Products Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Drug-Device Combination Products Product Offered
11.1.3 GSK Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 GSK Main Business Overview
11.1.5 GSK Latest Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Information
11.2.2 Novo Nordisk Drug-Device Combination Products Product Offered
11.2.3 Novo Nordisk Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novo Nordisk Main Business Overview
11.2.5 Novo Nordisk Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Drug-Device Combination Products Product Offered
11.3.3 Eli Lilly Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca Drug-Device Combination Products Product Offered
11.4.3 AstraZeneca Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 AstraZeneca Main Business Overview
11.4.5 AstraZeneca Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Drug-Device Combination Products Product Offered
11.5.3 Sanofi Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Boston Scientific
11.6.1 Boston Scientific Company Information
11.6.2 Boston Scientific Drug-Device Combination Products Product Offered
11.6.3 Boston Scientific Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Boston Scientific Main Business Overview
11.6.5 Boston Scientific Latest Developments
11.7 Abbott
11.7.1 Abbott Company Information
11.7.2 Abbott Drug-Device Combination Products Product Offered
11.7.3 Abbott Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Abbott Main Business Overview
11.7.5 Abbott Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Drug-Device Combination Products Product Offered
11.8.3 Boehringer Ingelheim Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Medtronic
11.9.1 Medtronic Company Information
11.9.2 Medtronic Drug-Device Combination Products Product Offered
11.9.3 Medtronic Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Medtronic Main Business Overview
11.9.5 Medtronic Latest Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Drug-Device Combination Products Product Offered
11.10.3 Mylan Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Mylan Main Business Overview
11.10.5 Mylan Latest Developments
11.11 3M
11.11.1 3M Company Information
11.11.2 3M Drug-Device Combination Products Product Offered
11.11.3 3M Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 3M Main Business Overview
11.11.5 3M Latest Developments
11.12 Hisamitsu
11.12.1 Hisamitsu Company Information
11.12.2 Hisamitsu Drug-Device Combination Products Product Offered
11.12.3 Hisamitsu Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Hisamitsu Main Business Overview
11.12.5 Hisamitsu Latest Developments
11.13 Smith & Nephew
11.13.1 Smith & Nephew Company Information
11.13.2 Smith & Nephew Drug-Device Combination Products Product Offered
11.13.3 Smith & Nephew Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Smith & Nephew Main Business Overview
11.13.5 Smith & Nephew Latest Developments
11.14 Molnlycke
11.14.1 Molnlycke Company Information
11.14.2 Molnlycke Drug-Device Combination Products Product Offered
11.14.3 Molnlycke Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Molnlycke Main Business Overview
11.14.5 Molnlycke Latest Developments
11.15 Teleflex
11.15.1 Teleflex Company Information
11.15.2 Teleflex Drug-Device Combination Products Product Offered
11.15.3 Teleflex Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Teleflex Main Business Overview
11.15.5 Teleflex Latest Developments
11.16 BD
11.16.1 BD Company Information
11.16.2 BD Drug-Device Combination Products Product Offered
11.16.3 BD Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 BD Main Business Overview
11.16.5 BD Latest Developments
11.17 Lepu Medical
11.17.1 Lepu Medical Company Information
11.17.2 Lepu Medical Drug-Device Combination Products Product Offered
11.17.3 Lepu Medical Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Lepu Medical Main Business Overview
11.17.5 Lepu Medical Latest Developments
11.18 MicroPort
11.18.1 MicroPort Company Information
11.18.2 MicroPort Drug-Device Combination Products Product Offered
11.18.3 MicroPort Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 MicroPort Main Business Overview
11.18.5 MicroPort Latest Developments
11.19 Terumo
11.19.1 Terumo Company Information
11.19.2 Terumo Drug-Device Combination Products Product Offered
11.19.3 Terumo Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Terumo Main Business Overview
11.19.5 Terumo Latest Developments
11.20 B. Braun
11.20.1 B. Braun Company Information
11.20.2 B. Braun Drug-Device Combination Products Product Offered
11.20.3 B. Braun Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 B. Braun Main Business Overview
11.20.5 B. Braun Latest Developments
11.21 Antares Pharma
11.21.1 Antares Pharma Company Information
11.21.2 Antares Pharma Drug-Device Combination Products Product Offered
11.21.3 Antares Pharma Drug-Device Combination Products Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Antares Pharma Main Business Overview
11.21.5 Antares Pharma Latest Developments
12 Research Findings and Conclusion
Table 1. Drug-Device Combination Products Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Drug-Coated Device
Table 3. Major Players of Prefilled Drug Delivery Systems
Table 4. Major Players of Nebulizer and Inhaler
Table 5. Major Players of Transdermal Delivery System
Table 6. Major Players of Others
Table 7. Drug-Device Combination Products Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Drug-Device Combination Products Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Drug-Device Combination Products Market Size Market Share by Type (2017-2022)
Table 10. Drug-Device Combination Products Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Drug-Device Combination Products Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Drug-Device Combination Products Market Size Market Share by Application (2017-2022)
Table 13. Global Drug-Device Combination Products Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Drug-Device Combination Products Revenue Market Share by Player (2020-2022)
Table 15. Drug-Device Combination Products Key Players Head office and Products Offered
Table 16. Drug-Device Combination Products Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Drug-Device Combination Products Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Drug-Device Combination Products Market Size Market Share by Regions (2017-2022)
Table 21. Americas Drug-Device Combination Products Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Drug-Device Combination Products Market Size Market Share by Country (2017-2022)
Table 23. Americas Drug-Device Combination Products Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Drug-Device Combination Products Market Size Market Share by Type (2017-2022)
Table 25. Americas Drug-Device Combination Products Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Drug-Device Combination Products Market Size Market Share by Application (2017-2022)
Table 27. APAC Drug-Device Combination Products Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Drug-Device Combination Products Market Size Market Share by Region (2017-2022)
Table 29. APAC Drug-Device Combination Products Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Drug-Device Combination Products Market Size Market Share by Type (2017-2022)
Table 31. APAC Drug-Device Combination Products Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Drug-Device Combination Products Market Size Market Share by Application (2017-2022)
Table 33. Europe Drug-Device Combination Products Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Drug-Device Combination Products Market Size Market Share by Country (2017-2022)
Table 35. Europe Drug-Device Combination Products Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Drug-Device Combination Products Market Size Market Share by Type (2017-2022)
Table 37. Europe Drug-Device Combination Products Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Drug-Device Combination Products Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Drug-Device Combination Products Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Drug-Device Combination Products Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Drug-Device Combination Products Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Drug-Device Combination Products
Table 46. Key Market Challenges & Risks of Drug-Device Combination Products
Table 47. Key Industry Trends of Drug-Device Combination Products
Table 48. Global Drug-Device Combination Products Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Drug-Device Combination Products Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Drug-Device Combination Products Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Drug-Device Combination Products Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Drug-Device Combination Products Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Drug-Device Combination Products Market Size Market Share Forecast by Application (2023-2028)
Table 54. GSK Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 55. GSK Drug-Device Combination Products Product Offered
Table 56. GSK Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. GSK Main Business
Table 58. GSK Latest Developments
Table 59. Novo Nordisk Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 60. Novo Nordisk Drug-Device Combination Products Product Offered
Table 61. Novo Nordisk Main Business
Table 62. Novo Nordisk Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Novo Nordisk Latest Developments
Table 64. Eli Lilly Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 65. Eli Lilly Drug-Device Combination Products Product Offered
Table 66. Eli Lilly Main Business
Table 67. Eli Lilly Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Eli Lilly Latest Developments
Table 69. AstraZeneca Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 70. AstraZeneca Drug-Device Combination Products Product Offered
Table 71. AstraZeneca Main Business
Table 72. AstraZeneca Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. AstraZeneca Latest Developments
Table 74. Sanofi Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 75. Sanofi Drug-Device Combination Products Product Offered
Table 76. Sanofi Main Business
Table 77. Sanofi Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Sanofi Latest Developments
Table 79. Boston Scientific Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 80. Boston Scientific Drug-Device Combination Products Product Offered
Table 81. Boston Scientific Main Business
Table 82. Boston Scientific Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Boston Scientific Latest Developments
Table 84. Abbott Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 85. Abbott Drug-Device Combination Products Product Offered
Table 86. Abbott Main Business
Table 87. Abbott Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Abbott Latest Developments
Table 89. Boehringer Ingelheim Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 90. Boehringer Ingelheim Drug-Device Combination Products Product Offered
Table 91. Boehringer Ingelheim Main Business
Table 92. Boehringer Ingelheim Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Boehringer Ingelheim Latest Developments
Table 94. Medtronic Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 95. Medtronic Drug-Device Combination Products Product Offered
Table 96. Medtronic Main Business
Table 97. Medtronic Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Medtronic Latest Developments
Table 99. Mylan Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 100. Mylan Drug-Device Combination Products Product Offered
Table 101. Mylan Main Business
Table 102. Mylan Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Mylan Latest Developments
Table 104. 3M Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 105. 3M Drug-Device Combination Products Product Offered
Table 106. 3M Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. 3M Main Business
Table 108. 3M Latest Developments
Table 109. Hisamitsu Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 110. Hisamitsu Drug-Device Combination Products Product Offered
Table 111. Hisamitsu Main Business
Table 112. Hisamitsu Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. Hisamitsu Latest Developments
Table 114. Smith & Nephew Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 115. Smith & Nephew Drug-Device Combination Products Product Offered
Table 116. Smith & Nephew Main Business
Table 117. Smith & Nephew Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. Smith & Nephew Latest Developments
Table 119. Molnlycke Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 120. Molnlycke Drug-Device Combination Products Product Offered
Table 121. Molnlycke Main Business
Table 122. Molnlycke Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. Molnlycke Latest Developments
Table 124. Teleflex Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 125. Teleflex Drug-Device Combination Products Product Offered
Table 126. Teleflex Main Business
Table 127. Teleflex Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Teleflex Latest Developments
Table 129. BD Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 130. BD Drug-Device Combination Products Product Offered
Table 131. BD Main Business
Table 132. BD Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. BD Latest Developments
Table 134. Lepu Medical Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 135. Lepu Medical Drug-Device Combination Products Product Offered
Table 136. Lepu Medical Main Business
Table 137. Lepu Medical Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Lepu Medical Latest Developments
Table 139. MicroPort Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 140. MicroPort Drug-Device Combination Products Product Offered
Table 141. MicroPort Main Business
Table 142. MicroPort Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. MicroPort Latest Developments
Table 144. Terumo Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 145. Terumo Drug-Device Combination Products Product Offered
Table 146. Terumo Main Business
Table 147. Terumo Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 148. Terumo Latest Developments
Table 149. B. Braun Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 150. B. Braun Drug-Device Combination Products Product Offered
Table 151. B. Braun Main Business
Table 152. B. Braun Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 153. B. Braun Latest Developments
Table 154. Antares Pharma Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 155. Antares Pharma Drug-Device Combination Products Product Offered
Table 156. Antares Pharma Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 157. Antares Pharma Main Business
Table 158. Antares Pharma Latest Developments
List of Figures
Figure 1. Drug-Device Combination Products Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug-Device Combination Products Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drug-Device Combination Products Market Size Market Share by Type in 2021
Figure 7. Drug-Device Combination Products in Hospital andClinic
Figure 8. Global Drug-Device Combination Products Market: Hospital andClinic (2017-2022) & ($ Millions)
Figure 9. Drug-Device Combination Products in Retail Pharmacies
Figure 10. Global Drug-Device Combination Products Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 11. Drug-Device Combination Products in Other
Figure 12. Global Drug-Device Combination Products Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Drug-Device Combination Products Market Size Market Share by Application in 2021
Figure 14. Global Drug-Device Combination Products Revenue Market Share by Player in 2021
Figure 15. Global Drug-Device Combination Products Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Drug-Device Combination Products Market Size 2017-2022 ($ Millions)
Figure 17. APAC Drug-Device Combination Products Market Size 2017-2022 ($ Millions)
Figure 18. Europe Drug-Device Combination Products Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Drug-Device Combination Products Market Size 2017-2022 ($ Millions)
Figure 20. Americas Drug-Device Combination Products Value Market Share by Country in 2021
Figure 21. Americas Drug-Device Combination Products Consumption Market Share by Type in 2021
Figure 22. Americas Drug-Device Combination Products Market Size Market Share by Application in 2021
Figure 23. United States Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Drug-Device Combination Products Market Size Market Share by Region in 2021
Figure 28. APAC Drug-Device Combination Products Market Size Market Share by Application in 2021
Figure 29. China Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Drug-Device Combination Products Market Size Market Share by Country in 2021
Figure 36. Europe Drug-Device Combination Products Market Size Market Share by Type in 2021
Figure 37. Europe Drug-Device Combination Products Market Size Market Share by Application in 2021
Figure 38. Germany Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Application in 2021
Figure 46. Egypt Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Drug-Device Combination Products Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 52. APAC Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 53. Europe Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 55. United States Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 56. Canada Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 59. China Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 60. Japan Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 61. Korea Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 63. India Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 64. Australia Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 65. Germany Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 66. France Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 67. UK Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 68. Italy Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 69. Russia Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 70. Spain Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 73. Israel Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Drug-Device Combination Products Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...